missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IFN-gamma Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
458.00 EUR
Specifications
| Gene ID (Entrez) | 3458 |
|---|---|
| Molecular Weight (g/mol) | 16.9 kDa |
| Name | IFN-gamma |
| Quantity | 100 μg |
| Source | E. coli-derived human IFN-gamma protein Gln24-Gln166 with an N-terminal Met |
| Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
|
18786996
|
R&D Systems™
285-IF-100 |
Lyophilized from a 0.2μm filtered solution in Sodium Succinate, Mannitol and Tween™ 80 with BSA as a carrier protein. |
458.00 EUR
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18377487
|
R&D Systems™
285-IF-100/CF |
Lyophilized from a 0.2μm filtered solution in Sodium Succinate, Mannitol and Tween™ 80. |
458.00 EUR
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Measured in anti-viral assays using HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. The ED50 for this effect is 0.15-0.75 ng/mL.Specifications
| 3458 | |
| IFN-gamma | |
| E. coli-derived human IFN-gamma protein Gln24-Gln166 with an N-terminal Met | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 16.9 kDa | |
| 100 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title